Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nuvalent Inc Cl A (NQ: NUVL )

72.33 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 72.33
Bid (Size) 68.64 (1)
Ask (Size) 76.19 (1)
Prev. Close 72.33
Today's Range 72.33 - 72.33
52wk Range 38.98 - 89.39
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally
Although short-squeeze stocks to buy present great risk, betting against the bears can also yield dramatically robust returns. 
Via InvestorPlace
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga

Performance

YTD
-4.95%
-4.95%
1 Month
-9.66%
-9.66%
3 Month
+5.68%
+5.68%
6 Month
-0.65%
-0.65%
1 Year
+72.58%
+72.58%

More News

Read More
NUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024
Via InvestorPlace
Recap: Nuvalent Q4 Earnings
Via Benzinga
Recap: Nuvalent Q3 Earnings
Via Benzinga
7 Biotech Stocks to Get In Now Before Investors Catch On
Via InvestorPlace
Where Nuvalent Stands With Analysts
Via Benzinga
Why Nuvalent Stock Was Soaring Wednesday
Via The Motley Fool
Why Nuvalent Stock Tanked on Tuesday
Via The Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Via Benzinga
Why Nuvalent Stock Skyrocketed 35% This Week
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold
Via Benzinga
Expert Ratings for Nuvalent
Via Benzinga
Nuvalent: Q1 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
Via Benzinga
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
Via Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying
Via Benzinga
$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
Via Benzinga
TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.